Fig. 2: Selected immunomodulatory therapies currently in clinical development.
From: Therapeutic approaches to modulate the immune microenvironment in gliomas
Overview of selected novel immunomodulatory agents that are discussed in this review article. These agents include oncolytic viruses, vaccine therapies, cellular therapies and other systemic therapies such as antibodies and peptides. The figure was created using BioRender.com.
